Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830746 · ClinicalTrials.gov registry record · NA
ASCEND CSP IDE Study
A NA study of Heart Failure and Ventricular Arrythmia, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 414
- Enrollment target
- 20
- Study locations
NCT06830746: Active NA study of Heart Failure and Ventricular Arrythmia, sponsored by Abbott Medical Devices.
NCT06830746 is a NA study of Heart Failure and Ventricular Arrythmia that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 414 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06830746, a NA study of Heart Failure and Ventricular Arrythmia, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 414 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participating centers from the United States, Canada, Europe, and Asia Pacific.
Primary Outcome
Freedom from CSP ICD Lead-related Serious Adverse Device Effects (SADEs) through 3 months post-implant for subjects in which the CSP ICD Lead implant was attempted
Conditions Studied
Interventions
- DEVICE LBBAP Implant with a CSP ICD Lead
Study Locations (20)
Pennsylvania
- Geisinger Medical Center - Danville
- Lancaster General Hospital - Lancaster
- Hospital of the University of Pennsylvania - Philadelphia
California
- Premier Cardiology, Inc. - Newport Beach
- University of California at San Diego (UCSD) Medical Center - San Diego
Queensland
- The Prince Charles Hospital - Chermside
- Princess Alexandra Hospital - Woolloongabba
Alabama
- Heart Center Research LLC - Huntsville
Arizona
- Banner University Medical Center Phoenix - Phoenix
Arkansas
- Arrhythmia Research Group - Jonesboro
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2028-05 |
| Phase | NA |
What the registry record for NCT06830746 still lists
NCT06830746 is an interventional study that assigns participants to a tested intervention. The registered 414 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which LBBAP Implant with a CSP ICD Lead is the first listed.
NCT06830746 names 20 study sites across 16 states, led by Pennsylvania, California, Queensland.
Frequently Asked Questions
What is clinical trial NCT06830746 about?
NCT06830746 is a clinical study titled "ASCEND CSP IDE Study". This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participatin...
What is the current status of trial NCT06830746?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 414 participants. The study started on 2025-04-11. Estimated completion is 2028-05.
What conditions does trial NCT06830746 study?
This clinical trial studies the following conditions: Heart Failure, Ventricular Arrythmia.
What interventions are being tested in trial NCT06830746?
The interventions under investigation include: LBBAP Implant with a CSP ICD Lead (DEVICE).
Who is sponsoring clinical trial NCT06830746?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06830746 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06830746's enrollment target sits among peer trials
414 115th of 397 higher than 283 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI